Women's health discussion
forums, research news and
women's health issues.
DISCUSSION FORUMS...

Trying To Conceive

Surviving Miscarriage

Overcoming Infertility

Reproductive Health

General Health

Contraception

Pregnancy

Parenting

Babies and Toddlers

Relationships

Mental Health

Diet & Weight


ARTICLES ABOUT...

Relationships

Sexual Dysfunction

Looking Good

STDs

Men

Contraception

Reproductive Health

Conceiving

Pregnancy

Incontinence

Mental Health

Children's Health

Eating Well

Healthy Living

Supplements

Menopause

Weight Issues

Breast Cancer

Custom Search

1 January 2013
Study finds no link between antidepressants and stillbirth

European researchers have found no significant association between selective serotonin reuptake inhibitor (SSRI) antidepressant use during pregnancy and risk of stillbirth, neonatal death, or postneonatal death. The results of the study, that included nearly 30,000 women from Nordic countries, appear in the latest issue of the JAMA.

Depression during pregnancy is common, with prevalence ranging between 7 percent and 19 percent in developed countries. It has been associated with poorer pregnancy outcomes, including increased risk of preterm delivery, which in turn may cause neonatal morbidity and mortality.

The use of SSRI meds to treat depression during pregnancy has previously been associated with congenital anomalies, neonatal withdrawal syndrome, and persistent pulmonary hypertension of the newborn.

In the new study, Olof Stephansson, of the Karolinska Institutet, Stockholm, investigated whether SSRI exposure during pregnancy was associated with increased risks of stillbirth, neonatal death, and postneonatal death. This involved obtaining information on maternal use of SSRIs from prescription registries. Maternal characteristics, pregnancy, and neonatal outcomes were obtained from patient and medical birth registries. The researchers estimated relative risks of stillbirth, neonatal death, and postneonatal death associated with SSRI use during pregnancy taking into account maternal characteristics and previous psychiatric hospitalization.

The researchers found that SSRI use was not associated with stillbirth, neonatal death, or postneonatal death. They issued a cautionary note, however. "Decisions regarding use of SSRIs during pregnancy must take into account other perinatal outcomes and the risks associated with maternal mental illness," they warn.

Related:
Discuss this article in our forum
Antidepressants and miscarriage: the risk quantified
Antidepressants causing lactation problems
Pregnancy Doesn't Protect Against Depression
Birth Defects And Antidepressants

Source: JAMA


Discussion Forums     About Us     Privacy
Your use of this website indicates your agreement to our terms of use.
2002 - 2013 Aphrodite Women's Health and its licensors. All rights reserved.